v3.25.2
SCHEDULE OF REVENUE RECOGNITION (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Product Information [Line Items]        
Total net revenue $ 1,269,483 $ 2,397,652 $ 3,123,080 $ 4,804,043
Health Care, Patient Service [Member]        
Product Information [Line Items]        
Total net revenue [1]     2,512,449 4,209,955
Histology Service Fees [Member]        
Product Information [Line Items]        
Total net revenue     572,358 530,053
Medical Director Fees [Member]        
Product Information [Line Items]        
Total net revenue     33,897 33,193
Department of Defense Observational Studies [Member]        
Product Information [Line Items]        
Total net revenue     6,923
Other Revenues [Member]        
Product Information [Line Items]        
Total net revenue     $ 4,376 $ 23,919
[1] Patient services fees include direct billing for CyPath® Lung diagnostic test of approximately $323,000 and $199,000 for the six months ended June 30, 2025 and 2024, respectively.